Chengchun Liu

549 total citations
11 papers, 144 citations indexed

About

Chengchun Liu is a scholar working on Epidemiology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chengchun Liu has authored 11 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Neurology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chengchun Liu's work include Acute Ischemic Stroke Management (9 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Chengchun Liu is often cited by papers focused on Acute Ischemic Stroke Management (9 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Chengchun Liu collaborates with scholars based in China and United States. Chengchun Liu's co-authors include Chun‐Rong Liang, Xiaoshu Li, Yan‐Jiang Wang, Wuwei Feng, Lin Lu, Wei Li, Jinhua Chen, Meng Zhang, Meng Zhang and Wei Li and has published in prestigious journals such as Stroke, Journal of the Neurological Sciences and American Journal of Neuroradiology.

In The Last Decade

Chengchun Liu

9 papers receiving 141 citations

Peers

Chengchun Liu
Chengchun Liu
Citations per year, relative to Chengchun Liu Chengchun Liu (= 1×) peers Patrizia Nencini

Countries citing papers authored by Chengchun Liu

Since Specialization
Citations

This map shows the geographic impact of Chengchun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengchun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengchun Liu more than expected).

Fields of papers citing papers by Chengchun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengchun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengchun Liu. The network helps show where Chengchun Liu may publish in the future.

Co-authorship network of co-authors of Chengchun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengchun Liu. A scholar is included among the top collaborators of Chengchun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengchun Liu. Chengchun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Wěi, Yi Yang, Xue Ma, et al.. (2024). Preoperative and intraoperative tirofiban during endovascular thrombectomy in large vessel occlusion stroke due to large artery atherosclerosis. European Journal of Neurology. 31(10). e16419–e16419. 4 indexed citations
2.
Liu, Chengchun, et al.. (2024). MCA Parallel Anatomic Scanning MR Imaging–Guided Recanalization of a Chronic Occluded MCA by Endovascular Treatment. American Journal of Neuroradiology. 45(9). 1227–1229.
3.
Liu, Chengchun, Qinghua Wang, Yuhao Liu, et al.. (2023). Association of Adipokines with Alzheimer’s Disease in a Chinese Cohort. Journal of Alzheimer s Disease. 96(2). 523–533.
4.
Liu, Chengchun, Wei Li, Ximing Nie, et al.. (2023). Efficacy and safety of early anticoagulation after endovascular treatment in patients with atrial fibrillation. Stroke and Vascular Neurology. 8(5). 405–412. 4 indexed citations
5.
Liu, Chengchun, et al.. (2021). Artery diameter ratio after recanalization in endovascular therapy for acute ischemic stroke: a new predictor of clinical outcomes. Neuroradiology. 64(4). 785–793. 1 indexed citations
6.
Wang, Huan, et al.. (2020). Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 29(8). 104829–104829. 5 indexed citations
7.
Li, Wei, Xiaoshu Li, Chengchun Liu, et al.. (2019). Intravenous tirofiban therapy for patients with capsular warning syndrome. Stroke and Vascular Neurology. 4(1). 22–27. 11 indexed citations
8.
Hu, Zicheng, et al.. (2018). Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit. Experimental and Therapeutic Medicine. 16(2). 1014–1020. 11 indexed citations
9.
Lu, Lin, Wei Li, Chengchun Liu, et al.. (2017). Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies. Journal of the Neurological Sciences. 383. 175–179. 16 indexed citations
10.
Yi, Xu, Wei Li, Qinhua Wang, et al.. (2016). Predictive Factors for the Spontaneous Recanalization of Large and Middle Cerebral Arteries after Acute Occlusion. Journal of Stroke and Cerebrovascular Diseases. 25(8). 1896–1900. 9 indexed citations
11.
Li, Wei, Lin Lu, Meng Zhang, et al.. (2016). Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients. Stroke. 47(10). 2649–2651. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026